-
Security Type
-
Crowd SAFE
-
Min Investment
-
$100
-
Offering Date
-
November 18, 2022
-
Expected Close Date
-
August 14, 2023
-
Target Raise
-
$25.00K-$1.24M
-
No. Investors
-
47
-
Security Price
-
$1
- Number of Employees
- 30
- Cash
- $1,252
- Revenue
- $180,841
- Short Term Debt
- $791,194
- Cost of Goods
- $420,788
- Long Term Debt
- $0
- Net Income
- $-685,525
Company Description
Combining a consumer's personal, medical and genetic data into a digital identity allows BioCertica to securely link a company's products and services to the exact genetic needs of the consumer.
Key Deal Facts
Pioneering hyper-personalization: Digital ID x Personal Genomics
Digital ID securely linking commerce to the genetic needs of the consumer
Easily integrated | Consensual | Secure
12-mo revenue of $350k
Fully monetized Biologin product launching in Q4
Management Team / Advisory Board Bios
Gert van Wyk
Founder & CEO
Arno Smit
Co-founder & CPO
Faris Zacina
Lead Investor & Strategist
Amer Diglisic
Product & Tech Lead
Mirna Dragaš
Product Manager
Carel van Heerden
Lab Manager
Ajdin Halać
Software Developer | Backend Lead
Jo McBride
Lab Advisor
Alisson Diab
Lab Advisor
Céline Haarhoff
Country Manager
Maryka Niemand
Head of Marketing
Rethabile Ramakaba
Practitioner Consultant
Abigail Crafford
Practitioner Consultant
Hazel Mantshiu
Practitioner Consultant
Jolandie Pieterse
Practitioner Consultant
Edin Hamzic
CSO
Nermin Đuzić
Content Specialist
Jamie Fernandez
Content Writer
Amar Kasapovic
Product Designer
Jonine Möller
Content Writer
Meliha Dejkić
Software Developer
Selma Papić
Software Engineer
Pierre Vermeulen
Head of Sales
Mishke van den Berg
Brand Director
Marilu Meiring
Head of Distribution
Nicolette Louw
Customer Relations
Jan Vorster
Genomics Expert
Monja van Zyl
CFO